source
- Eli Lilly's 340B claims data deadline passes, sparking potential new disputeEli Lilly set a deadline for hospitals to submit 340B drug‑pricing program claims data under its new policy. The deadline has now passed, and the company has not indicated what actions it will tak…
- Biopharma CEOs see soaring compensation, new analysis to be discussed liveEndpoints News released the first installment of its annual biopharma compensation project, breaking down the pay of the industry’s highest-earning CEOs. The company will host a Post-Hoc Live web…